ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

154
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
31 Jul 2024 13:31

KRX’s September Major Rebalancing Events: Why We Should Focus on KRX BBIG

This post examines flow trading opportunities arising from the KRX BBIG's September rebalancing, focusing on the impact of four stocks in the top...

Logo
387 Views
Share
bullishAlteogen Inc
31 Jul 2024 07:05

KRX New Deal Index Rebalance Preview: Potential Changes as Review Period Ends Today

We expect at least 1 change for each of the Secondary Battery, Bio, Internet, Game and BBIG indices. Flows are pretty big on some of the stocks and...

Logo
431 Views
Share
31 Jul 2024 06:00

KRX Short Interest Weekly (Jul 26th): Shinhan Financia, Amorepacific, Kb Financial, Skc, Posco

We analyzed KRX short interest report for the past week and highlighted short interest changes in Shinhan Financia, Amorepacific, Kb Financial,...

Logo
290 Views
Share
24 Jul 2024 06:00

KRX Short Interest Weekly (Jul 19th): Doosan Enerbility

We analyzed KRX short interest report for the past week and highlighted short interest changes in Doosan Enerbility (034020 KS).

Logo
402 Views
Share
10 Jul 2024 06:00

KRX Short Interest Weekly (Jul 5th): Hlb, Posco

We analyzed KRX short interest report for the past week and highlighted short interest changes in Hlb(028300 KS), Posco(005490 KS).

Logo
286 Views
Share
x